IDO1 and non-small cell lung carcinoma: In tumors such as non-small cell lung cancer (NSCLC) and esophageal squamous cell cancer, higher IDO1 and TDO expression in kynurenine pathway is associated with higher TNM stage and shorter overall survival [70].